These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6607930)
1. Dysfunction of humoral immunity in anergic surgical patients: absence of anti-tetanus IgG antibody production. Mazaheri R; Rode HN; Abikar K; Ing A; Nohr C; Gordon J J Clin Immunol; 1984 Jan; 4(1):65-70. PubMed ID: 6607930 [TBL] [Abstract][Full Text] [Related]
2. IgG1 is the predominant subclass of in vivo- and in vitro- produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells. Stevens R; Dichek D; Keld B; Heiner D J Clin Immunol; 1983 Jan; 3(1):65-9. PubMed ID: 6600745 [TBL] [Abstract][Full Text] [Related]
3. Antibody synthesis by bone marrow cells in vitro following primary and booster tetanus toxoid immunization in humans. Kodo H; Gale RP; Saxon A J Clin Invest; 1984 May; 73(5):1377-84. PubMed ID: 6609170 [TBL] [Abstract][Full Text] [Related]
4. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations. Lum LG; Culbertson NJ J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031 [TBL] [Abstract][Full Text] [Related]
5. In vitro analysis of humoral immunity in antibody deficiency with normal immunoglobulins. Saxon A; Kobayashi RH; Stevens RH; Singer AD; Stiehm ER; Siegel SC Clin Immunol Immunopathol; 1980 Oct; 17(2):235-44. PubMed ID: 6967789 [No Abstract] [Full Text] [Related]
6. Human IgA antibody and immunoglobulin production after in vivo tetanus toxoid immunization: size and surface membrane phenotype analysis. Thiele CJ; Morrow CD; Stevens RH J Clin Immunol; 1982 Oct; 2(4):327-34. PubMed ID: 7142369 [TBL] [Abstract][Full Text] [Related]
7. The selective role of membrane IgG in the antigen-induced inhibition of human in vitro antibody synthesis. Stevens RH; Benveniste E; Pineda E J Immunol; 1982 Jan; 128(1):398-401. PubMed ID: 6798112 [TBL] [Abstract][Full Text] [Related]
8. 12-O-Tetradecanoylphorbol-13-acetate (TPA) directly inhibits spontaneous immunoglobulin secretion by in vivo antigen-induced human lymphoblastoid B cells. Brieva JA; Louie JS; Stevens RH J Clin Immunol; 1984 Jul; 4(4):280-6. PubMed ID: 6611348 [TBL] [Abstract][Full Text] [Related]
9. Respective roles of immune and nutritional factors in the priming of the immune response in the elderly. Moulias R; Devillechabrolle A; Lesourd B; Proust J; Marescot MR; Doumerc S; Favre-Berrone M; Congy F; Wang A Mech Ageing Dev; 1985; 31(2):123-37. PubMed ID: 3877221 [TBL] [Abstract][Full Text] [Related]
10. Age-related decrease in frequencies of B-cell precursors and specific helper T cells involved in the IgG anti-tetanus toxoid antibody production in humans. Kishimoto S; Tomino S; Mitsuya H; Nishimura H Clin Immunol Immunopathol; 1982 Oct; 25(1):1-10. PubMed ID: 6217937 [No Abstract] [Full Text] [Related]
11. Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination. Burns EA; Lum LG; L'Hommedieu G; Goodwin JS J Gerontol; 1993 Nov; 48(6):B231-6. PubMed ID: 8227990 [TBL] [Abstract][Full Text] [Related]
12. Transient immunoglobulin and antibody production. Occurrence in two patients with common varied immunodeficiency. Zielinski CC; Mutschlechner R; Schwarz G; Eibl MM Arch Intern Med; 1983 Oct; 143(10):1937-40. PubMed ID: 6605128 [TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro humoral immunity in surgical patients. Nohr CW; Christou NV; Rode H; Gordon J; Meakins JL Ann Surg; 1984 Sep; 200(3):373-80. PubMed ID: 6465987 [TBL] [Abstract][Full Text] [Related]
14. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody. Geha RS J Immunol; 1983 Apr; 130(4):1634-9. PubMed ID: 6601133 [TBL] [Abstract][Full Text] [Related]
15. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization. Stevens RH; Saxon A J Clin Invest; 1978 Dec; 62(6):1154-60. PubMed ID: 311781 [TBL] [Abstract][Full Text] [Related]
16. Systemic antibody deficiency in patients without serum immunoglobulin deficiency or with selective IgA deficiency. French MA; Harrison G Clin Exp Immunol; 1984 Apr; 56(1):18-22. PubMed ID: 6713729 [TBL] [Abstract][Full Text] [Related]
17. Specific in vivo and in vitro antibody response to tetanus toxoid immunization. Ershler WB; Moore AL; Hacker MP Clin Exp Immunol; 1982 Sep; 49(3):552-8. PubMed ID: 6756720 [TBL] [Abstract][Full Text] [Related]
18. Comparisons of the effect of naturally acquired maternal pertussis antibodies and antenatal vaccination induced maternal tetanus antibodies on infant's antibody secreting lymphocyte responses and circulating plasma antibody levels. Ahmad SM; Alam J; Afsar NA; Huda N; Kabir Y; Qadri F; Raqib R; Stephensen CB Hum Vaccin Immunother; 2016 Apr; 12(4):886-93. PubMed ID: 27176823 [TBL] [Abstract][Full Text] [Related]
19. Antigen-specific antibody responses of lymphocytes to tetanus toxoid after human marrow transplantation. Shiobara S; Lum LG; Witherspoon RP; Storb R Transplantation; 1986 May; 41(5):587-92. PubMed ID: 2939606 [TBL] [Abstract][Full Text] [Related]
20. [In vitro immunization for the production of antibodies to tetanus toxin and toxoid. 2. Antibody production in lymphocyte cultures]. Jahn S; Kiessig ST; Grunow R; von Baehr R Allerg Immunol (Leipz); 1987; 33(2):89-94. PubMed ID: 2959130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]